The store will not work correctly when cookies are disabled.
N-(4-Ethoxyphenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA3310318
PubChem CID: 24100528
Max Phase: Preclinical
Molecular Formula: C17H17N3O2
Molecular Weight: 295.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOc1ccc(NC(=O)c2c(C)nc3ccccn23)cc1
Standard InChI: InChI=1S/C17H17N3O2/c1-3-22-14-9-7-13(8-10-14)19-17(21)16-12(2)18-15-6-4-5-11-20(15)16/h4-11H,3H2,1-2H3,(H,19,21)
Standard InChI Key: UHLULZJWBNDCPM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
3.2576 -4.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5431 -4.6768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5431 -5.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2576 -5.9143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9721 -5.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9721 -4.6768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4291 -3.4574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2496 -3.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5852 -4.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3921 -4.2963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6471 -5.0810 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9755 -3.7130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6621 -2.6567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7724 -3.9265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3558 -3.3431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1526 -3.5567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3662 -4.3535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7828 -4.9369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9859 -4.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1631 -4.5671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7464 -3.9837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5433 -4.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
10 11 2 0
10 12 1 0
9 10 1 0
8 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
21 22 1 0
20 21 1 0
17 20 1 0
12 14 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.34 | Molecular Weight (Monoisotopic): 295.1321 | AlogP: 3.29 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.24 | CX LogP: 2.10 | CX LogD: 2.10 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -2.34 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |